Categories
Search

Archive for November, 2009

Anti Inflammatory Drug May Prevent Type 2 Diabetes

Monday, November 30th, 2009

Researchers at the Joslin Diabetes Center are reporting that an budget-priced anti-inflammatory drug equivalent to aspirin, salsalate, may prevent strain 2 diabetes by lowering blood glucose and reducing inflammation.

The study, which appears in the February to be decided disagree of Diabetes Vigilance, is a small, proof-of-principal clinical trial, but is promising plenty to spur three more trials to see if the drug, salsalate, can also treat diabetes by lowering blood glucose, slow the progression of coronary artery affliction in those with metabolic syndrome, and perhaps anticipate diabetes in those at high risk.

“This is far-out because salsalate has a allowable safety promote after myriad years of end, is inexpensive to make and appears to prepare the potential to diminish blood glucose,” said Allison B. Goldfine, M.D., dispose researcher on the boning up, Manage of Clinical Research at Joslin and Assistant Professor at Harvard Medical School. “It may be functional in preventing diabetes.”

While it has long been known that high doses of aspirin could break blood glucose levels, the risk of tolerate bleeding is too pongy chief to grant for this treatment to be used, she said. It has also been known for specific years that inflammatory markers and proteins are elevated in people with diabetes and that aspirin can reduce redness, she noted.

Animal studies had shown aspirin could be effective, but since it could not safely be Euphemistic pre-owned in humans at steep doses, the researchers concern about deceitful a trendy drug. Goldfine suggested trying salsalate, a non-steroidal, anti-inflammatory medication that is similar to aspirin but does not cause bleeding in patients at risk for diabetes. The cheap drug has been used as regards decades to play host to arthritis.

The treacherous-masked, placebo-controlled study of 20 obese young adults found that salsalate substantially reduced blood glucose levels as spout as inflammation, and, as a result, may grieve their chance of developing type 2 diabetes.

“Our study was the first to look at the metabolic changes that be brought to someone’s attention when you send salsalate to obese people who have not yet developed diabetes and we’re exceedingly encouraged by what we found,” she said.

The review ground that those who took 4 grams of salsalate per day in favour of identical month reduced fasting glucose levels by 13 percent and levels of C-reactive protein, a marker in support of redness, by 34 percent. Earlier studies have implicated inflammation in the advance of fount 2 diabetes and heart disease.

The proof-of-assets survey concludes that salsalate reduces glycemia and may improve inflammatory cardiovascular risk indexes in the stout. The findings be supportive of the proposition that long-lasting inflammation contributes to rotundity-akin abnormal blood glucose and suggests that targeting inflammation may provide a group therapy for the duration of diabetes avoidance.

This study was funded by grants from the National Institutes of Constitution; the Joslin Diabetes and Endocrinology Research Center; a Joslin Eli Lilly Fellowship Allowance; and the Clinical Investigator Training Program of Harvard-MIT Health Sciences and Technology-Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc., and Merck & Company, Inc.

Other researchers participating in the go into were Amy Fleischman, M.D., MMSc; Steven E. Shoelson, M.D., Ph.D.; and Raquel Bernier, B.S.

Additional Salsalate Trials

The encouraging results from this proof-of-principal study have prompted very many related studies.

Dr. Goldfine is the pre-eminent investigator in one workroom that targets inflammation using salsalate in patients with metabolic syndrome, assessing effects of coronary artery plaque size. This project is funded by the National Heart, Lung and Blood Institute and hand down begin enrollment in winter 2008. There is a lifestyle intervention arm to this study being run by Dr. Ernest Schaefer of The Jean Mayer USDA Human Nutrition Center on Aging at Tufts University and Dr. Francine Welty of Beth Israel Deaconess Medical Center.

The lifestyle ruminate on, called Targeting INflammation using SALsalate to ban CardioVascular Disease (TINSAL-CVD), purpose look at the effects of lifestyle intervention (diet, distress and omega-3 fatty acid supplement) or salsalate compared to placebo to reduce rise or promote regression of unfalteringly and flexuous coronary artery calcification as assessed by multi-detector CT angiography, a to some degree new method to image the coronary arteries. Patients are randomized to lifestyle, salsalate or placebo with images of the coronary arteries at baseline and after 30 months of intervention.

A second study being headed by Drs. Goldfine and Shoelson is using salsalate in patients with type 2 diabetes to target redness and thus lower blood glucose. This sanctum sanctorum, called TINSAL-T2D, is ongoing and is funded by the National Organization of Diabetes and Digestive and Kidney Diseases. http://tinsalt2d.org

A third study headed by Dr. Goldfine and Dr. Peter Reaven of the Carl T. Hayden VA Medical Center in Phoenix targets inflammation using salsalate in patients with impaired glucose tolerance to make progress insulin sensitivity. This exploration, called TINSAL-IGT, is ongoing and is funded by the VA.

The various studies using salsalate in connection with treatment and prevention of diabetes stem from work initiated at Joslin dating back to the 1990s when the molecular target of high dose aspirin was identified. Dr. Shoelson, who holds the Helen and Morton Adler Chair and is Precede of the Section on Cellular and Molecular Physiology at Joslin, was the key to demonstrate the importance of this mutinous pathway, IKK/NFkB, in animal models of diet-induced weight and diabetes. These “bench” studies showed the benefits of aspirin in improving metabolism in these animals.

These ongoing studies, including the one-liner being reported today, show the advancement that has been made in alluring these lab studies and bringing them to patients in a to some degree short age of dead for now. After Shoelson’s initial discovery, some had considered looking to develop a new drug to aim IKK/NFkB, since it was known that aspirin had too great a risk of bleeding. But Goldfine came up with the idea of worrying salsalate, a dull already developed and on the market.

“This was substantial to hurriedness the bench to bedside observations as much of the pharmacokinetic and long-stipulations safety data is established,” she said. “Although the stimulant was around, no one ever thought of using it in diabetes/metabolic syndrome.”

Drugs currently available to treat diabetes do not completely butt the IKK/NFkB pathway. As a come to pass, these studies promise to lead to some novel therapies allowing for regarding the disease.

Alongside Joslin Diabetes Center

Joslin Diabetes Center is the world’s largest diabetes clinic, diabetes delving center and provider of diabetes education. Founded in 1898, Joslin is an sovereign nonprofit institution affiliated with Harvard Medical School. Joslin research is a cooperate of more than 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, attached with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, empower Joslin to realize the potential of, implement and dividend innovations that immeasurably on life the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission.

Joslin Diabetes Center
One Joslin Pl.
Boston, MA 02215
United States
http://www.joslin.org

Health Minister Opens Our New Fitness To Practise Premises

Saturday, November 28th, 2009

The NMC’s dedicated Good shape to Exercise premises were officially opened yesterday by the Orderly Under-Secretary for Health Services, Ann Keen.

Ms Keen, the first nurse till the cows come home to hold ministerial bit, unveiled the commemorative plaque at the new modern premises at the Centrium building, 61 Aldwych, London and expressed confidence in the changes fascinating role at the NMC.

The origin of Centrium is a evident inscribe of the major infrastructure and systems improvements that the NMC is putting in place for its Wholesomeness to Practise operation. The improved facilities, features including five hearings rooms and dedicated areas for witnesses, respondents, and members of the free, are part of a wider programme of rise at the NMC.

Ann Keen said “I felicitate the NMC on the excellent skill they be suffering with created,” she said “The NMC accept addressed finished problems and are at present in a leaning to trade fitness to practice issues much more effectively and efficiently than had been possible before.”

NMC Moderator, Professor Tony Hazell, said “The opening of these aver of the dexterity premises is another important milestone in on account of the NMC. In addition, we keep a continuing programme of investment in FtP shaft training, in recruitment and in improving our IT systems. These improvements and investments are building on the good foundations established by the organisation in years gone by. But there remains a the whole kit still to do and there can be no room for complacency as we proceed to invest in safeguarding the health and wellbeing of patients and the purchasers who we serve.”

Notes

1. The Nursing and Midwifery Congress (NMC) is the regulator for the sake of two professions: nursing and
midwifery. To be eligible to work as a nurse or midwife in the UK, they must be registered with
the NMC. There are currently more than 660,000 nurses and midwives on the register.

2. The Fitness to Practise premises at the Centrium building ensures it is fit in search purpose, with:

- a comfortable, whiz space, with modern facilities and good transport links
- dedicated areas in support of witnesses, respondents, and members of the public
- five state of the art hearings rooms fully accessible and enabled for people with disabilities (eg: audio loops)
- apposite and appropriate keeping apart of stake and public areas
- a separate entrance for staff and panellists
- a modish roomy-plan working conditions on staff

3. The NMC Fitness to Train began to move hearings to Centrium from the previous premises, 180 Oxford Lane, in January 2009.

4. The majority of aptness to exercise cases for the duration of England registrants will be held at the creative premises. When scheduling or individual cases require it, additional venues may be used. Hearings in place of Wales and Scotland-based registrants are held, when required, in those countries.

5. Weekly hearings schedules are within reach in advance on the Wholesomeness to Practise page at http://www.nmc-uk.org

Nursing & Midwifery Council

Bird Flu Movie Like Showing Air-Crash Film On A Plane

Wednesday, November 25th, 2009

ABC will be showing a silver screen called ‘Fatal Phone - Bird Flu in America’. Isn’t this similar to showing the film ‘Jaws’ to a group of surfers, or ‘Titanic’ to passengers on a voyage ocean, or ‘The Exorcist’ to a group of children just once they go to bed, or one of the many skate crash movies to passengers on an airplane?

The film shows all-out panic in the streets, piles of inanimate bodies being burned, whole city areas closed disappointing, soldiers patrolling all over the place, barbed wire sectioning - total chaos.

The movie’s aim, clearly, is to get Americans more able for the duration of a doable flu pandemic. More promising it will enterprising millions of people anxious and raise the possibility that total panic resolution interfere out of pocket no consequence how destructive or mild a pandemic may be.

The movie appears tonight on TV in the USA.

Public officials and health experts say the movie depicts a super-worse-in the event that ground, whole that is ever so unlikely to happen anywhere in the world. Uniform with the severe flu pandemic of 1918 - Spanish Flu - was dwarfed by the scenes and depictions in this silent picture.

Purchasers salubriousness authorities, health care professionals and bird flu experts should prefer to expressed attention apropos the effects of this picture. Even the US Be influenced of Health and Humanitarian Services had to come out and explain some facts that motion picture watchers may not realise.

The cover does not explain that a mutated H5N1 virus that could spread from human-to-human would probably be much less deadly to humans than the present one. The present H5N1 strain needs to recoup deep down into the forgiving lungs to make a person ill. That is why humans cannot surprise it definitively and cannot spread it easily - an infected person who coughs hardly exhales any of the viruses because they are so deep down. For the virus to infect humans easily it needs to learn how to infect the upper-respiratory tract. It needs to mutate to do this. However, the upper-respiratory critique is much easier to treat - survival rates are much, much higher.

According to people who deceive seen the movie, it is both boring and so badly made as to be completely unscary. I hope this is remarkably the case.

The movie supposes that the H5N1 bird flu virus tone mutates into a horrible waste time. A man returns from Hong Kong and coughs after landing in Virginia. People panic, body bags in large quantity, seniors starve and unbroken urban areas are closed eccentric. As the pandemic grows the background rosy effects are notched up a few decibels to touch viewers more highly-strung and frantic.

It is equal partiality to make a movie there a location after the upshot, such as Karakatoa or Titanic. But making a film, a deliberately sensationalist mist, already a expected event, seems irresponsible and dangerous.

I fear that all this movie will achieve, will be:

1. Public fear and heightened appetite.
2. A deluge of email spam present ‘cheap solutions’ to the ‘impending flu pandemic’.
3. More people docile to lay out during these ’solutions’.

Written by: Christian Nordqvist
Columnist: Medical Newsflash Today

Copyright: Medical Advice Today

Not to be reproduced without licence of Medical Newsflash Today

Archive